Siemens Healthineers (OTCMKTS:SMMNY) Trading 2.2% Higher – Still a Buy?

Siemens Healthineers AG (OTCMKTS:SMMNY)’s share price traded up 2.2% during mid-day trading on Tuesday . The stock traded as high as $26.94 and last traded at $26.92. 56,391 shares traded hands during mid-day trading, a decline of 48% from the average session volume of 107,564 shares. The stock had previously closed at $26.3525.

Analysts Set New Price Targets

A number of research firms have weighed in on SMMNY. Royal Bank Of Canada started coverage on shares of Siemens Healthineers in a report on Wednesday, December 17th. They set a “moderate buy” rating on the stock. Zacks Research lowered shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a report on Friday, December 12th. Finally, Deutsche Bank Aktiengesellschaft downgraded Siemens Healthineers from a “buy” rating to a “hold” rating in a report on Thursday, December 4th. Three analysts have rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Buy”.

Siemens Healthineers Price Performance

The stock’s 50-day moving average price is $25.65 and its 200-day moving average price is $26.86.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.